AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SULFADOXINE/PYRIMETHAMINE AMODIAQUINE

12 registrations across 3 African markets— 12 active

Markets with SULFADOXINE/PYRIMETHAMINE AMODIAQUINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
AQUZON SP KID TABLETS (Each dispersible tablet contains Sulfadoxine/Pyrimethamine/Amodiaquine 250mg/12.5mg/76.5mg)🇬🇭GhanaactiveFeb 2031
AQUZON SP KID TABLETS (Each dispersible tablet contains Sulfadoxine/Pyrimethamine/Amodiaquine 250mg/12.5mg/76.5mg)🇬🇭GhanaactiveFeb 2031
LARIDOX-AQ FORTE DISPERSIBLE TABLETS🇬🇭GhanaactiveJun 2030
LARIDOX-AQ FORTE DISPERSIBLE TABLETS🇬🇭GhanaactiveJun 2030
LARIDOX-AQ DISPERSIBLE TABLETS🇬🇭GhanaactiveJun 2030
LARIDOX-AQ DISPERSIBLE TABLETS🇬🇭GhanaactiveJun 2030
SPAQ-CO® Disp 250mg/12.5mg /76.5mg
Dispersible Tablet
🇰🇪KenyaShanghai Fosun Pharmaceutical Industrial…activeMay 2029
SPAQ-CO® Disp 500mg/25mg/153mg
Dispersible Tablet
🇰🇪KenyaShanghai Fosun Pharmaceutical Industrial…activeMay 2029
SPAQ-CO
Comprimé dispersible / 500mg / 25 mg 153 mg
🇸🇳SenegalGuilin Pharmaceutical Co., Ltd.active
SPAQ-CO
Comprimé dispersible / 250mg / 12,5 mg 76,5 mg
🇸🇳SenegalGuilin Pharmaceutical Co., Ltd.active
SPAQ-CO
Comprimé dispersible / 500mg / 25 mg 153 mg
🇸🇳SenegalGuilin Pharmaceutical Co., Ltd.active
SPAQ-CO
Comprimé dispersible / 250mg / 12,5 mg 76,5 mg
🇸🇳SenegalGuilin Pharmaceutical Co., Ltd.active

SULFADOXINE/PYRIMETHAMINE AMODIAQUINE in Africa — Regulatory Overview

SULFADOXINE/PYRIMETHAMINE AMODIAQUINE is registered across 3 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Senegal, Kenya. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.